Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001355250-09-000018
Filing Date
2009-10-08
Accepted
2009-10-08 16:48:00
Documents
15
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PERIOD ENDING JUNE 30, 2009 form10k.htm 10-K 1252120
2 SARBANES OXLEY EXCHANGE ACT RULES 13A-15(F) AND 15D-15(F)) exh31_1.htm EX-31.1 10509
3 SARBANES OXLEY EXCHANGE ACT RULES 13A-15(F) AND 15D-15(F)) exh31_2.htm EX-31.2 10679
4 SARBANES OXLEY CERTIFICATION PURSUANT TO SECTION 906 exh32_1.htm EX-32.1 8090
5 CONTRACT AGREEMENT GIRINDUS AMERICA, INC. exh10_17.htm EX-10.17 27111
6 exh4_1.htm EX-4.1 439
7 cfigure1.jpg GRAPHIC 6430
8 exh2_1.htm EX-4.2 438
9 figure3.jpg GRAPHIC 56920
10 figure23.jpg GRAPHIC 56920
11 chart1h.jpg GRAPHIC 31125
12 chart2h.jpg GRAPHIC 36537
13 chart3hh.jpg GRAPHIC 40008
14 chart4h.jpg GRAPHIC 33559
15 chart5h.jpg GRAPHIC 24335
  Complete submission text file 0001355250-09-000018.txt   1705632
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

EIN.: 134303398 | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-52321 | Film No.: 091112432
SIC: 2834 Pharmaceutical Preparations